Interim Measures Order News Today

Illumina, Inc. today announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is anticipated to spin off from Illumina on June 24, 2024, and has applied to list on Nasdaq as "GRAL." "Today's announcement marks a?milestone...

When-issued trading expected to begin on or about June 12, 2024Record date for distribution of GRAIL shares will be June 13, 2024Distribution date for GRAIL shares anticipated to be June 24, 2024SAN...

Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares

GRAIL to host Capital Markets Day on May 13, 2024  SAN DIEGO, May 6, 2024 /PRNewswire/ -- Illumina, Inc. today announced that it has publicly filed a Form 10 registration statement with the U.S....

Menlo Park - GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and BeniComp, a customized health plan provider, today announced the availability of...

Validation Results Using a Plasma-based Targeted Methylation Assay Demonstrate Potential to Identify High-Risk Patients who Might Benefit From Additional TreatmentMENLO PARK, Calif. & CAMBRIDGE, England & SEOUL, South Korea--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early wh...

HCA Healthcare to Offer GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test; HCA Healthcare's Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal HCA Healthcare, Inc.

HCA Healthcare to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test; HCA Healthcare’s Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal ...

Diagnostic Evaluations Were Consistent With GalleriⓇ-Predicted Cancer Signal Origin in 78% of Study Participants Whole-Body Imaging Did Not Contribute to Di ...

FinancialContent fully hosted finance channel